fr en
Our locations
  • Pharmaceutical Solutions
    Pharmaceutical Solutions
    • Pharmaceutical Solutions
    • Small molecules APIs
      • Small molecules APIs
      • Custom Development & Manufacturing
      • Proprietary APIs
      • Proprietary Intermediates
      • Drug Delivery & Materials
    • Consumer Health APIs
      • Consumer Health APIs
      • Acetylsalicylic Acid
      • Salicylic Acid
      • Methyl Salicylate
      • Paracetamol
      • Para Amino Phenol
      • Allyl Alcohol
    • Life science Inputs
      • Life science Inputs
      • Hygiene & Disinfectants
      • Diisopropyl Ether (DIPE)
      • Isopropanol (IPA)
      • Isopropyl Acetate (IPAC)
    • Other
      • Other
      • In vitro diagnostic
  • Specialty Ingredients
    Specialty Ingredients
    • Specialty Ingredients
    • Cosmetics
      • Cosmetics
      • Custom Cosmetics
      • Active
      • Functional
    • Custom Manufacturing
      • Custom Manufacturing
      • Custom Processing
      • Fine chemicals
      • Catalyst Re-Impregnation
    • Lubricants Additives
      • Lubricants Additives
      • Custom Greases
      • Metal Protection
      • Metalworking
    • Electronics
      • Electronics
      • Micro-Electronics
      • Printed & Organic Electronics
    • Solvents
      • Solvents
      • Oxygenated Solvents
      • Low VOC Solvents
      • Solvent Recovery
    • Mineral Specialties
      • Mineral Specialties
      • Bicarbonates
      • Soda Ash
      • Sodium Silicates
      • Nabion
    • Upstream platform
      • Upstream platform
      • Phenol & Acetone
      • Essentials
    • Specialty Chemicals
      • Specialty Chemicals
      • Acetophenone (ACPH)
      • Alpha Methyl Styrene (AMS)
      • Cumene
      • Cumene Hydroperoxide (CHP)
      • Di Iso Propyl Benzene (DIPB)
  • R&D Services
    R&D Services
    • R&D Services
    • Market offering
      • Market offering
      • Pharma early phase development
      • Pharma late phase development
      • Custom ingredients
      • Cosmetics & Personal care
    • Key expertise
      • Key expertise
      • Analytical Excellence
      • Artificial Intelligence
      • Biocatalysis
      • Multi-catalysis
      • Flow Chemistry
      • High-Potency APIs (HPAPIs)
      • Polymers
      • Solid state characterization
    • R&D Excellence centres
      • R&D Excellence centres
      • Seqens'Lab
      • Protéus (Biocatalysis)
      • Boston’Lab (Early phase projects)
      • Aramon'Lab (Drug Delivery Polymers)
      • Montreal' Lab (Electronics)
      • Middlesbrough'Lab (Cosmetics & Fine chem)
    • Business Partners hosting
      • Business Partners hosting
      • Drug repositionning
      • Toxicology
  • About Seqens
    About Seqens
    • SEQENS GROUP
    • OUR HISTORY
    • OUR VALUES
    • GROUP GOVERNANCE
    • SCIENTIFIC COMMITTEE
    • OUR PARTNERS
    • COMPLIANCE
  • Material safety data sheet
  • Careers
    Careers
    • JOBS
    • SPONTANEOUS APPLICATION
  • Newsroom
  • Contact
fr en
logo-seqens
Locations Products Commitments
logo-seqens
  • Pharmaceutical Solutions
    Pharmaceutical Solutions
    • Small molecules APIs
      • Custom Development & Manufacturing
      • Proprietary APIs
      • Proprietary Intermediates
      • Drug Delivery & Materials
    • Consumer Health APIs
      • Acetylsalicylic Acid
      • Salicylic Acid
      • Methyl Salicylate
      • Paracetamol
      • Para Amino Phenol
      • Allyl Alcohol
    • Life science Inputs
      • Hygiene & Disinfectants
      • Diisopropyl Ether (DIPE)
      • Isopropanol (IPA)
      • Isopropyl Acetate (IPAC)
    • Other
      • In vitro diagnostic
  • Specialty Ingredients
    Specialty Ingredients
    • Cosmetics
      • Custom Cosmetics
      • Active
      • Functional
    • Custom Manufacturing
      • Custom Processing
      • Fine chemicals
      • Catalyst Re-Impregnation
    • Lubricants Additives
      • Custom Greases
      • Metal Protection
      • Metalworking
    • Electronics
      • Micro-Electronics
      • Printed & Organic Electronics
    • Solvents
      • Oxygenated Solvents
      • Low VOC Solvents
      • Solvent Recovery
    • Mineral Specialties
      • Bicarbonates
      • Soda Ash
      • Sodium Silicates
      • Nabion
    • Upstream platform
      • Phenol & Acetone
      • Essentials
    • Specialty Chemicals
      • Acetophenone (ACPH)
      • Alpha Methyl Styrene (AMS)
      • Cumene
      • Cumene Hydroperoxide (CHP)
      • Di Iso Propyl Benzene (DIPB)
  • R&D Services
    R&D Services
    • Market offering
      • Pharma early phase development
      • Pharma late phase development
      • Custom ingredients
      • Cosmetics & Personal care
    • Key expertise
      • Analytical Excellence
      • Artificial Intelligence
      • Biocatalysis
      • Multi-catalysis
      • Flow Chemistry
      • High-Potency APIs (HPAPIs)
      • Polymers
      • Solid state characterization
    • R&D Excellence centres
      • Seqens'Lab
      • Protéus (Biocatalysis)
      • Boston’Lab (Early phase projects)
      • Aramon'Lab (Drug Delivery Polymers)
      • Montreal' Lab (Electronics)
      • Middlesbrough'Lab (Cosmetics & Fine chem)
    • Business Partners hosting
      • Drug repositionning
      • Toxicology
Top of page
  • About Seqens
  • Material safety data sheet
  • Careers
  • Newsroom
  • Contact

SEQENSgroup

  • SEQENS GROUP
  • OUR HISTORY
  • OUR VALUES
  • GROUP GOVERNANCE
  • SCIENTIFIC COMMITTEE
  • OUR PARTNERS
  • COMPLIANCE
  • JOBS
  • SPONTANEOUS APPLICATION
Share

Newsroom

Home Newsroom
General / Press Release Covid-19

COVID – 19 LATEST UPDATES

07th may 2020

SEQENS mobilizes its innovation to support the unprecedented research on the covid-19 and prepares its unique industrial network for anti-virus production, for…

Read more
Protéus 17th february 2021

High performance enzyme ready for shipment

Protéus by Seqens’ team has recently developed and produced a highly efficient enzyme. It is operated for the biocatalytic production of…

Read more
Protéus 17th february 2021

Focus on : Precious transition metal catalysts replacement

During the last 5 years, large price increases were observed for precious transition metal catalysts: Palladium price has increased by a factor…

Read more
Products & Technologies / Protéus 08th february 2021

Biocatalyst for Sucrose conversion into Fructo-Oligosaccharides

Sugar-reduction in food is at the heart of everyone’s concerns. Fructo OligoSaccharides (FOS) are a natural sweet-tasting, low-calorie alternative that is widely…

Read more
Protéus / SD-CSR 22nd january 2021

Protéus by Seqens is now certified Gold Ecovadis

Protéus-By-Seqens team, located in Nîmes (France), is pleased to announce having achieved the “Gold” level following the evaluation of its Corporate Social…

Read more
General / Protéus / SD-CSR 26th october 2020

Protéus by Seqens winner of the Potier Prize 2020

This year, the Pierre Potier 2020 prize was awarded to Protéus by Seqens, the group’s biotech subsidiary specialized in enzymatic biocatalysis,…

Read more
Protéus 15th september 2020

Conference: “Biocatalysis from lab to industrial scale”

On July 27th, during the Protein Engineering Congress USA, Protéus by Seqens gave a talk on « Biocatalysis from lab to industrial scale », right…

Read more
General / Protéus 30th june 2020

Biocatalysis Webinar – Protéus by Seqens – Pôle IAR – May 6th, 2020

REPLAY OF THE WEBINAR About BIOCATALYSIS On May 6th, Proteus by Seqens co-organized, together with the French bioeconomy cluster IAR a webinar on…

Read more
General / Protéus 05th june 2020

A new article published by Proteus in the special issue of OPRD journal

engineering of enzymatic cascades from D-serine This special issue highlights innovative organic chemistry research from academic and industrial chemists across France and its…

Read more
General / Products & Technologies / Protéus Covid-19 15th may 2020

What flow chemistry and biocatalysis bring to synthesize a typical small molecule candidate against Covid-19 epidemic

Efficient and safe process design combining SEQENS technical capabilities: Brilacidin as a case study As already mentioned in our previous article (“Seqens…

Read more
General / Products & Technologies / Protéus Covid-19 30th april 2020

SEQENS biocatalytic approach to improve the synthesis of Danoprevir, a Covid-19 antiviral candidate

Focusing on biocatalysis for asymmetric synthesis and precious metal catalysts replacement The covid-19 crisis triggered an unprecedented mobilization of pharmaceutical research. Mid-April, 440…

Read more

Join the SEQENS teams !

See our job offers

A question? A need?Contact us

Contact us

Follow the seqens evolution onsocial medias

  • Home
  • Newsroom
  • Press / Media
  • About cookies
  • GTC
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site web. Si vous continuez à utiliser ce site, nous supposerons que vous en êtes satisfait.

Gérer mes préférences

Certaines des fonctionnalités de ce site (partage de contenu sur les réseaux sociaux, lecture vidéo en direct) sont basées sur des services fournis par des sites tiers. Ces fonctions stockent des cookies qui permettent à ces sites de suivre votre navigation. Ces cookies ne sont stockés que si vous donnez votre consentement. Vous pouvez vous renseigner sur la nature des cookies placés, les accepter ou les refuser soit globalement pour l'ensemble du site et tous les services, soit service par service.

Cookies obligatoires

Cookies d'analyse d'audience

Cookies liés aux réseaux sociaux

Enregistrer
Ok

DISCOVER OUR NEWS

Learn more